| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |